Category Archives: Zocor

Featured Stories
Retailers Accused of Selling Fraudulent Herbal Supplements

Major Retailers Accused of Selling Fraudulent Herbal Supplements

The NYS attorney general’s office has accused four national retailers of selling fraudulent dietary supplements.

Read More

Pradaxa Named in Most FDA Adverse Event Reports for Deaths, Hemorrhage, Kidney Failure and Stroke

The controversial blood thinner, Pradaxa, surpassed all other drugs monitored by the U.S. Food & Drug Administration (FDA) in adverse event reports made to the agency last year. According to the Institute for Safe Medicine Practices’ (ISMP) latest QuarterWatch report, Pradaxa also topped the list for reports of deaths, ...

Read More

First DePuy ASR Hip Implant Lawsuits Head to Trial in December, January

The first trials involving lawsuits filed against DePuy Orthopaedics by recipients of its recalled ASR Hip Implants will begin later this year, and early next year. The first is slated to start on December 3, 2012 in state court in Las Vegas, Nevada. A second DePuy ASR hip implant lawsuit ...

Read More

Study Finds SSRI Antidepressant Side Effects Outweigh Their Benefits

A new study is raising more concerns about the safety of commonly used antidepressants, including selective serotonin reuptake (SSRI) inhibitor antidepressants. Investigators who conducted the study, which is published in the journal Frontiers in Psychology, posit that increased knowledge of the negative effects of SSRIs and other antidepressants could reduce ...

Read More

Cancer Groups Issue Statement for Regulation of E-cigarettes

Cancer Groups Issue Statement Calling for Research and Regulation of E-cigarettes

The American Society of Clinical Oncology & the American Association for Cancer Research are calling on the government to regulate e-cigarettes.

Read More

Parker Waichman Representing Another Louisiana Plaintiff in Actos Bladder Cancer Lawsuit

A Louisiana man has become the latest to claim that his taking the type 2 diabetes drug Actos resulted in developing bladder cancer. He has filed a lawsuit against the Japanese manufacturer of the drug and the marketer of it in the U.S., claiming they failed to warn about this ...

Read More

FDA Gives 7 Companies Go Ahead To Market Generic Plavix

The U.S. Food & Drug Administration (FDA) just gave seven companies the go-ahead to market generic Plavix. Plavix is a blood thinner prescribed for the prevention of blood clots, heart attacks, and which has been linked to serious side effects such as the heart attacks and strokes it is supposed to ...

Read More

Fracking Releasing Hazardous Chemicals into Local Waterways

Fracking Releasing Hazardous Chemicals into Local Waterways

Study shows two hazardous chemicals—ammonium & iodide—are being released & spilled into Pennsylvania and W.Virginia waterways from fracking operations in Marcellus shale.

Read More

Pradaxa Associated with more Complications than Warfarin, According to Early Study Findings

Early results from the largest study to date to compare Pradaxa and warfarin indicate that in a real-world setting, Pradaxa causes more complications than decades-old warfarin. The preliminary study results were announced last week, during the 2012 Thrombosis and Hemostasis Summit of North America.

Read More

First DePuy ASR Hip Implant Lawsuits Head to Trial in December, January

The first trials involving lawsuits filed against DePuy Orthopaedics by recipients of its recalled ASR Hip Implants will begin later this year, and early next year. The first is slated to start on December 3, 2012 in state court in Las Vegas, Nevada. A second DePuy ASR hip implant lawsuit ...

Read More

Study Shows Increased Risk of Type 2 Diabetes for Statin Users

Increased Risk of Type 2 Diabetes for Statin Users

A new study from Finland has confirmed previous findings about a link between the use of cholesterol-lowering statin drugs and higher risk of Type 2 diabetes. This study, published in the journal Diabetologia, avoided some of the limitations of earlier … Continue reading

Posted in Health Concerns, Pharmaceuticals, Zocor | Tagged , , , |

Statins May Raise Risk of Cataracts

New Canadian research shows that cholesterol-lowering statin drugs may raise the risk of developing cataracts, a clouding of the lens of the eye. While statins such as Zocor (simvastatin), Crestor (rosuvastatin), and Lipitor (atorvastatin) protect many people from heart attack … Continue reading

Posted in Crestor, Health Concerns, Pharmaceuticals, Zocor |

Statin Drugs Increase Risk of Diabetes

According to a study just published online in the medical journal the Lancet, cholesterol-lowering statin drugs can directly increase the risk of diabetes. While statins have previously been associated with higher rates of Type 2 diabetes, it was not clear … Continue reading

Posted in Birth Defects, Crestor, Health Concerns, Pharmaceuticals, Zocor |

New Research Identifies Serious Design Flaws in Many Animal-Based Drug Studies

animal-testing-flawed-statin-drugs

Recently published research reports serious design flaws in many of the pharmaceutical studies involving animals that precede drug trials in humans. A research team led by pharmacologist Lisa Bero of the University of California, San Francisco, analyzed animal studies of … Continue reading

Posted in Crestor, Pharmaceuticals, Zocor |

Study: Statins May Reduce Exercise Benefits in Overweight, Obese Adults

Statins_Affect_Excercise

A new study has found that statins, used to lower blood cholesterol levels, may reduce exercise benefits for overweight adults. Statins rank among the best selling drugs in the world and are typically prescribed to people with obesity, diabetes, and … Continue reading

Posted in Crestor, Pharmaceuticals, Zocor |

Study: High-Dose Statins Linked to Acute Kidney Injury

A recent BMJ article reviewed the connection between statin medications and kidney damage. The just-published article reviewed data from over 2 million patient records dated from 1997 to 2008, said the Drug Safety Monitor. Records originated from Canadian provinces and … Continue reading

Posted in Crestor, Pharmaceuticals, Zocor |

Age-Related Cataracts Linked to Statin Use

People who use statins to lower their cholesterol may face a higher risk of developing age-related cataracts, according to a new study that appears in the August issue of Optometry and Vision Science.  According to the study, the association between … Continue reading

Posted in Crestor, Pharmaceuticals, Zocor | Tagged |

More Potent Statins Linked to Muscle Damage

Statin drugs prescribed to lower cholesterol levels are more likely to cause severe muscle injuries when taken at higher doses or when more potent forms of the drug are used. According to a ScienceDaily.com report on a new study from … Continue reading

Posted in Pharmaceuticals, Zocor | Tagged |

Statins May Leave Patients Fatigued, Study Finds

Cholesterol-lowering statins may leave patients fatigued, according to a new study. Statins are a class of prescription drugs used in combination with diet and exercise to lower the blood levels of low-density lipoprotein (LDL) cholesterol—so-called bad cholesterol. The research found … Continue reading

Posted in Pharmaceuticals, Zocor | Tagged |

FDA Warns Of Statin Interactions With HIV, Hepatitis C Drugs

The U.S. Food and Drug Administration (FDA) issued a warning concerning statin interactions with HIV and hepatitis C medications. The notification involved interactions between protease inhibitors and certain statin drugs, including Lipitor (Atorvastatin), Mevacor (Lovastatin), Crestor (Rosuvastatin), and Zocor (Simvastatin). … Continue reading

Posted in Crestor, Pharmaceuticals, Zocor |

© 2005-2017 Parker Waichman LLP ®. All Rights Reserved.